American Century Companies Inc Biotechnology

American Century Companies Inc

$168 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PSTX Poseida Therapeutics, Inc.	$815M	$403,000 0.0% of portfolio	42,073	Q4 2024 Added 19.95%
ABSI Absci Corp	$279M	$395,000 0.0% of portfolio	150,835	Q4 2024 Added 8.96%
AURA Aura Biosciences, Inc.	$220M	$392,000 0.0% of portfolio	47,701	Q4 2024 Added 33.92%
ATXS Astria Therapeutics, Inc.	$97.3M	$376,000 0.0% of portfolio	42,693	Q4 2024 Added 9.88%
ABCL Ab Cellera Biologics Inc.	$696M	$342,000 0.0% of portfolio	116,887	Q4 2024 Reduced 0.2%
TNGX Tango Therapeutics, Inc.	$155M	$341,000 0.0% of portfolio	110,448	Q4 2024 Added 12.37%
TRVI Trevi Therapeutics, Inc.	$377M	$332,000 0.0% of portfolio	78,143	Q4 2024 Added 44.74%
FATE Fate Therapeutics Inc	$88.3M	$326,000 0.0% of portfolio	197,704	Q4 2024 Added 6.63%
ALT Altimmune, Inc.	$285M	$322,000 0.0% of portfolio	44,742	Q4 2024 Added 35.77%
RZLT Rezolute, Inc.	$118M	$308,000 0.0% of portfolio	64,591	Q4 2024 Added 62.09%
TYRA Tyra Biosciences, Inc.	$449M	$307,000 0.0% of portfolio	22,142	Q4 2024 Reduced 48.51%
THRD Third Harmonic Bio, Inc.	$141M	$280,000 0.0% of portfolio	27,250	Q4 2024 Added 22.32%
TSVT 2seventy Bio, Inc.	$187M	$275,000 0.0% of portfolio	93,552	Q4 2024 Added 6.59%
CRBU Caribou Biosciences, Inc.	$63.3M	$254,000 0.0% of portfolio	159,822	Q4 2024 Added 9.17%
PRQR Pro Qr Therapeutics N.V.	$118M	$244,000 0.0% of portfolio	89,527	Q4 2024 New
DSGN Design Therapeutics, Inc.	$260M	$241,000 0.0% of portfolio	39,115	Q4 2024 Added 19.86%
CRDF Cardiff Oncology, Inc.	$163M	$234,000 0.0% of portfolio	53,955	Q4 2024 Added 12.84%
SMMT Summit Therapeutics Inc.	$3.97B	$231,000 0.0% of portfolio	12,971	Q4 2024 New
CRVS Corvus Pharmaceuticals, Inc.	$201M	$227,000 0.0% of portfolio	43,774	Q4 2024 Added 140.41%
NKTX Nkarta, Inc.	$73M	$226,000 0.0% of portfolio	90,952	Q4 2024 Added 8.83%
AMLX Amylyx Pharmaceuticals, Inc.	$214M	$223,000 0.0% of portfolio	59,310	Q4 2024 Added 181.77%
INZY Inozyme Pharma, Inc.	$38.9M	$219,000 0.0% of portfolio	79,349	Q4 2024 Added 11.62%
FDMT 4 D Molecular Therapeutics, Inc.	$127M	$216,000 0.0% of portfolio	38,785	Q4 2024 Added 12.89%
LRMR Larimar Therapeutics, Inc.	$110M	$215,000 0.0% of portfolio	56,294	Q4 2024 Added 32.76%
ENTA Enanta Pharmaceuticals Inc	$131M	$212,000 0.0% of portfolio	36,962	Q4 2024 Added 10.46%
ALDX Aldeyra Therapeutics, Inc.	$384M	$195,000 0.0% of portfolio	39,198	Q4 2024 Reduced 54.79%
TNYA Tenaya Therapeutics, Inc.	$26.5M	$180,000 0.0% of portfolio	126,008	Q4 2024 Added 5.0%
SEER Seer, Inc.	$110M	$176,000 0.0% of portfolio	76,314	Q4 2024 Reduced 0.42%
STRO Sutro Biopharma, Inc.	$40.2M	$171,000 0.0% of portfolio	93,033	Q4 2024 Added 29.08%
LIFE A Tyr Pharma Inc	$53.2M	$163,000 0.0% of portfolio	88,112	Q4 2024 Added 43.05%
VTYX Ventyx Biosciences, Inc.	$74.6M	$147,000 0.0% of portfolio	67,329	Q4 2024 Added 12.37%
ALEC Alector, Inc.	$111M	$107,000 0.0% of portfolio	56,735	Q4 2024 Reduced 11.13%
SGMO Sangamo Therapeutics, Inc	$136M	$107,000 0.0% of portfolio	105,337	Q4 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$109M	$97,000 0.0% of portfolio	32,084	Q4 2024 Added 8.85%
ABOS Acumen Pharmaceuticals, Inc.	$48.6M	$93,000 0.0% of portfolio	54,278	Q4 2024 Reduced 0.49%
KALV Kal Vista Pharmaceuticals, Inc.	$293M	$85,000 0.0% of portfolio	10,072	Q4 2024 Reduced 70.99%
PEPG Pep Gen Inc.	$41.8M	$85,000 0.0% of portfolio	22,605	Q4 2024 Reduced 0.77%
EPIX Essa Pharma Inc.	$69.6M	$83,000 0.0% of portfolio	46,373	Q4 2024 Reduced 0.6%
OLMA Olema Pharmaceuticals, Inc.	$167M	$68,000 0.0% of portfolio	11,738	Q4 2024 Reduced 59.56%
HOWL Werewolf Therapeutics, Inc.	$33.4M	$62,000 0.0% of portfolio	42,511	Q4 2024 Added 2.65%
ELYM Eliem Therapeutics, Inc.	$109M	$56,000 0.0% of portfolio	13,684	Q4 2024 Reduced 1.45%
ORMP Oramed Pharmaceuticals Inc.	$92.8M	$47,000 0.0% of portfolio	19,591	Q1 2024 Added 1.56%
MGNX Macrogenics Inc	$128M	$38,000 0.0% of portfolio	11,743	Q4 2024 New
HLVX Hille Vax, Inc.	$56.2M	$35,000 0.0% of portfolio	17,190	Q4 2024 Added 0.08%
VIGL Vigil Neuroscience, Inc.	$53.4M	$33,000 0.0% of portfolio	19,970	Q3 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	93,037	Q4 2024 Reduced 5.5%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.